共 50 条
- [41] Design, synthesis, and biological evaluation of monopyrrolinone-based HIV-1 protease inhibitors possessing augmented P2 side chainsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (04) : 859 - 863Smith, ABCharnley, AKHarada, HBeiger, JJCantin, LDKenesky, CSHirschmann, RMunshi, SOlsen, DBStahlhut, MWSchleif, WAKuo, LC
- [42] Potent, selective and orally bioavailable inhibitors of tumor necrosis factor-a converting enzyme (TACE):: Discovery of novel indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituentsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2666 - U2667Lu, ZhonghuiAnand, RajanLiu, RichardCovington, MaryanneVaddi, KrishnaQian, MingxinDuan, James J-W.Ott, Gregory R.
- [43] Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors.: Part 1:: P1 structure-activity relationships of the substituted 1-(2-naphthyl)-1H-pyrazole-5-carboxylamidesBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (12) : 1651 - 1655Jia, ZZJWu, YHHuang, WRGoldman, EZhang, PLWoolfrey, JWong, PHuang, BSinha, UPark, GReed, AScarborough, RMZhu, BY
- [44] Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors.: 4.: Incorporation of P1 lactam moieties as L-glutamine replacementsJOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (07) : 1213 - 1224Dragovich, PSPrins, TJZhou, RWebber, SEMarakovits, JTFuhrman, SAPatick, AKMatthews, DALee, CAFord, CEBurke, BJRejto, PAHendrickson, TFTuntland, TBrown, ELMeador, JWFerre, RAHarr, JEVKosa, MBWorland, ST
- [45] Inhibitors of the C2-symmetric HIV-1 protease:: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2′ side chainsJOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (20) : 4054 - 4061Hultén, JAndersson, HOSchaal, WDanielson, HUClasson, BKvarnström, IKarlén, AUnge, TSamuelsson, BHallberg, A
- [46] Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1′, a series of selective TNF-α converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-α releaseJOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (21) : 3351 - 3354Xue, CBHe, XHCorbett, RLRoderick, JWasserman, ZRLiu, RQJaffee, BDCovington, MBQian, MXTrzaskos, JMNewton, RCMagolda, RLWexler, RRDecicco, CP
- [47] 2-Pyridyl P1′-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors (A-792611 and A-790742) with Potential for Convenient Dosing and Reduced Side EffectsJOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2571 - 2586DeGoey, David A.Grampovnik, David J.Flentge, Charles A.Flosi, William J.Chen, Hui-juYeung, Clinton M.Randolph, John T.Klein, Larry L.Dekhtyar, TatyanaColletti, LynnMarsh, Kennan C.Stoll, VincentMamo, MulugetaMorfitt, David C.Nguyen, BachSchmidt, James M.Swanson, Sue J.Mo, HongmeiKati, Warren M.Molla, AkhteruzzamanKempf, Dale J.
- [48] How a β-D-Glucoside Side Chain Enhances Binding Affinity to Thrombin of Inhibitors Bearing 2-Chlorothiophene as P1 Moiety: Crystallography, Fragment Deconstruction Study, and Evaluation of Antithrombotic PropertiesJOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (20) : 8563 - 8575Belviso, Benny D.Caliandro, Roccode Candia, ModestoZaetta, GiorgiaLopopolo, GianfrancoIncampo, FrancescaColucci, MarioAltomare, Cosimo D.
- [49] DESIGN AND SYNTHESIS OF RENIN INHIBITORS - INCORPORATION OF TRANSITION-STATE ISOSTERE SIDE-CHAINS THAT SPAN FROM THE S1 TO THE S3 BINDING POCKETS AND EXAMINATION OF P3-MODIFIED RENIN INHIBITORSJOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (15) : 2893 - 2905PLUMMER, MSSHAHRIPOUR, AKALTENBRONN, JSLUNNEY, EASTEINBAUGH, BAHAMBY, JMHAMILTON, HWSAWYER, TKHUMBLET, CDOHERTY, AMTAYLOR, MDHINGORANI, GBATLEY, BLRAPUNDALO, ST
- [50] Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position:: Discovery of N-carboxymethyl-D-diphenylalanyl-L-prolyl[(5-amidino-2-thienyl)methyl]amideJOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (17) : 3612 - 3622Lee, KPark, CWJung, WHPark, HDLee, SHChung, KHPark, SKKwon, OHKang, MPark, DHLee, SKKim, EEYoon, SKKim, A